These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19218129)

  • 1. [Pilot-scale production and quality control of multiepitope hepatitis B virus DNA vaccine].
    Guo Y; Hui CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):118-20. PubMed ID: 19218129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction of a recombinant HBV DNA vaccine and its evaluation for specific cellular immune response in mice].
    Guo Y; Wang JF; Luo XC; Su J; Ma L; Zhang YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1803-5. PubMed ID: 17259125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X; Yang X; Jiang Y; Liu J
    Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of a multiple epitope DNA vaccine against hepatitis B virus].
    Luo LM; Li M; Xia H; Chen BH; Wang P; Hao WB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):517-21. PubMed ID: 15367337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.
    Yan J; Liu X; Wang Y; Jiang X; Liu H; Wang M; Zhu X; Wu M; Tien P
    J Gene Med; 2007 Feb; 9(2):107-21. PubMed ID: 17256801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
    Mancini M; Hadchouel M; Tiollais P; Michel ML
    J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccine manufacture: scale and quality.
    Cai Y; Rodriguez S; Hebel H
    Expert Rev Vaccines; 2009 Sep; 8(9):1277-91. PubMed ID: 19722898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
    Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide.
    Shao HJ; Chen L; Shen MS; Yu GF
    Acta Virol; 2003; 47(4):217-21. PubMed ID: 15068376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
    Cai Y; Rodriguez S; Rameswaran R; Draghia-Akli R; Juba RJ; Hebel H
    Vaccine; 2010 Feb; 28(8):2046-52. PubMed ID: 19896448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of immune responses in mice by hepatitis B virus large envelope DNA vaccine delivered by attenuated Salmonella typhimurium].
    Zhao P; Wang HW; Lu Y; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):601-4. PubMed ID: 12561207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
    Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
    Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B virus.
    Davis HL
    Mt Sinai J Med; 1999 Mar; 66(2):84-90. PubMed ID: 10100411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B.
    Swain WE; Heydenburg Fuller D; Wu MS; Barr LJ; Fuller JT; Culp J; Burkholder J; Dixon RM; Widera G; Vessey R; Roy MJ
    Dev Biol (Basel); 2000; 104():115-9. PubMed ID: 11713809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J; Gujar SA; Cova L; Michalak TI
    J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.